Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD)
- Status
- TERMINATED
- Phase
- PHASE2
Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF
- Status
- COMPLETED
- Phase
- PHASE3
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension
- Status
- TERMINATED
- Phase
- PHASE2
IL-1 Signal Inhibition in Alcoholic Hepatitis
- Status
- COMPLETED
- Phase
- PHASE2
Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
- Status
- COMPLETED
- Phase
- PHASE3
A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis
- Status
- COMPLETED
- Phase
- PHASE2
HDM201 Added to CT in R/R or Newly Diagnosed AML
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy of PEAR-004 in Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE2
Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- NA
Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).
- Status
- TERMINATED
- Phase
- PHASE1
Managed Access Programs for SEG101, Crizanlizumab
- Status
- AVAILABLE
- Phase
- N/A
Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function
- Status
- TERMINATED
- Phase
- PHASE2
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
- Status
- COMPLETED
- Phase
- PHASE3
This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).
- Status
- COMPLETED
- Phase
- PHASE3
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
- Status
- TERMINATED
- Phase
- PHASE3
Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3